BKV vs. TVTX
BKV (BKV Corp) and TVTX (Travere Therapeutics, Inc.) are both stocks. BKV operates in Oil & Gas E&P (Energy), while TVTX operates in Biotechnology (Healthcare). Over the past year, BKV returned 1.57% vs 285.39% for TVTX. At a 0.12 correlation, their price movements are largely independent.
Performance
BKV vs. TVTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BKV achieves a -9.58% return, which is significantly lower than TVTX's 44.33% return.
BKV
- 1D
- 1.74%
- 1M
- -13.22%
- YTD
- -9.58%
- 6M
- -8.16%
- 1Y
- 1.57%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TVTX
- 1D
- 1.87%
- 1M
- 24.13%
- YTD
- 44.33%
- 6M
- 59.81%
- 1Y
- 285.39%
- 3Y*
- 47.17%
- 5Y*
- 28.34%
- 10Y*
- 12.13%
BKV vs. TVTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
BKV BKV Corp | -9.58% | 14.17% | 28.19% |
TVTX Travere Therapeutics, Inc. | 44.33% | 119.35% | 19.81% |
Correlation
The correlation between BKV and TVTX is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Sep 26, 2024 | 0.12 |
Fundamentals
BKV:
$2.51B
TVTX:
$5.07B
BKV:
$3.24
TVTX:
-$0.49
BKV:
2.07
TVTX:
9.61
BKV:
1.09
TVTX:
51.32
BKV:
$1.08B
TVTX:
$536.20M
BKV:
$693.49M
TVTX:
$385.20M
BKV:
$544.16M
TVTX:
$11.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BKV vs. TVTX — Risk / Return Rank
BKV
TVTX
BKV vs. TVTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BKV Corp (BKV) and Travere Therapeutics, Inc. (TVTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BKV | TVTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.95 | ||
| Sortino ratioReturn per unit of downside risk | -4.21 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.58 | -0.53 |
| Calmar ratioReturn relative to maximum drawdown | 0.04 | 8.50 | -8.46 |
| Martin ratioReturn relative to average drawdown | 0.10 | 19.67 | -19.57 |
Loading charts...
Drawdowns
BKV vs. TVTX - Drawdown Comparison
The maximum BKV drawdown since its inception was -39.98%, smaller than the maximum TVTX drawdown of -85.43%. Use the drawdown chart below to compare losses from any high point for BKV and TVTX.
Loading charts...
Drawdown Indicators
| BKV | TVTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.98% | -85.43% | +45.45% |
Max Drawdown (1Y)Largest decline over 1 year | -24.97% | -33.49% | +8.52% |
Max Drawdown (3Y)Largest decline over 3 years | — | -69.51% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -83.12% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.64% | — |
Current DrawdownCurrent decline from peak | -23.66% | 0.00% | -23.66% |
Average DrawdownAverage peak-to-trough decline | -11.63% | -41.02% | +29.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.50% | 14.45% | -3.95% |
Volatility
BKV vs. TVTX - Volatility Comparison
The current volatility for BKV Corp (BKV) is 9.27%, while Travere Therapeutics, Inc. (TVTX) has a volatility of 15.36%. This indicates that BKV experiences smaller price fluctuations and is considered to be less risky than TVTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BKV | TVTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.27% | 15.36% | -6.09% |
Volatility (6M)Calculated over the trailing 6-month period | 26.17% | 52.61% | -26.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.42% | 71.64% | -28.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.28% | 66.50% | -23.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 43.28% | 58.37% | -15.09% |
Dividends
BKV vs. TVTX - Dividend Comparison
Neither BKV nor TVTX has paid dividends to shareholders.
Financials
BKV vs. TVTX - Financials Comparison
This section allows you to compare key financial metrics between BKV Corp and Travere Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BKV vs. TVTX - Profitability Comparison
BKV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BKV Corp reported a gross profit of 405.49M and revenue of 432.85M. Therefore, the gross margin over that period was 93.7%.
TVTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 127.20M. Therefore, the gross margin over that period was 0.0%.
BKV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BKV Corp reported an operating income of 86.03M and revenue of 432.85M, resulting in an operating margin of 19.9%.
TVTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported an operating income of -36.60M and revenue of 127.20M, resulting in an operating margin of -28.8%.
BKV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BKV Corp reported a net income of 44.08M and revenue of 432.85M, resulting in a net margin of 10.2%.
TVTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a net income of -37.10M and revenue of 127.20M, resulting in a net margin of -29.2%.
Frequently Asked Questions
BKV and TVTX have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TVTX has higher volatility (15.36%) compared to BKV (9.27%). In terms of maximum drawdown, BKV dropped -39.98% vs TVTX's -85.43%.
TVTX currently has the higher Sharpe Ratio (3.98 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BKV and TVTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer